Harnessing Natural γδ T Cell Receptors to Develop Safe Cellular Therapies for Solid Tumors

Time: 12:15 pm
day: Day One


• Understanding the unique cancer targeting properties of γδ TCRs
• Identifying the advantages of using γδT cells engineered to express a defined tumor-reactive natural γδTCR (TEG)
• Discussing applicability of γδ TCRs for building allogeneic T cell platforms that retain native recognition and signaling properties